373 related articles for article (PubMed ID: 17760815)
21. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
22. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells.
Arikawa T; Omura K; Morita I
J Cell Physiol; 2004 Sep; 200(3):400-6. PubMed ID: 15254968
[TBL] [Abstract][Full Text] [Related]
23. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
24. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
Lin TH; Yang RS; Tang CH; Lin CP; Fu WM
Bone; 2007 Oct; 41(4):562-74. PubMed ID: 17669705
[TBL] [Abstract][Full Text] [Related]
25. Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids.
Pagel CN; Song SJ; Loh LH; Tudor EM; Murray-Rust TA; Pike RN; Mackie EJ
Bone; 2009 May; 44(5):813-21. PubMed ID: 19442625
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
27. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
Coyle AT; O'Keeffe MB; Kinsella BT
FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
Kim HY; Kim JR; Kim HS
J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
Sabichi AL; Subbarayan V; Llansa N; Lippman SM; Menter DG
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1704-9. PubMed ID: 15533896
[TBL] [Abstract][Full Text] [Related]
31. Optimal compressive force induces bone formation via increasing bone morphogenetic proteins production and decreasing their antagonists production by Saos-2 cells.
Mitsui N; Suzuki N; Maeno M; Yanagisawa M; Koyama Y; Otsuka K; Shimizu N
Life Sci; 2006 May; 78(23):2697-706. PubMed ID: 16337660
[TBL] [Abstract][Full Text] [Related]
32. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
34. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
36. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison).
Desmarais JA; Lopes FL; Zhang H; Das SK; Murphy BD
Biol Reprod; 2007 Nov; 77(5):829-39. PubMed ID: 17615406
[TBL] [Abstract][Full Text] [Related]
37. [Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma: an in vitro experiment study].
Zhang H; Cheng JQ; Huang Q; Yang J; Shen B; Zhou ZK; Kang PD; Lian YY; Pei FX
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2603-8. PubMed ID: 19080706
[TBL] [Abstract][Full Text] [Related]
38. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells.
Lee SJ; Kim MS; Park JY; Woo JS; Kim YK
Toxicology; 2008 Jun; 248(2-3):121-9. PubMed ID: 18450357
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats.
García-Bueno B; Madrigal JL; Lizasoain I; Moro MA; Lorenzo P; Leza JC
Biol Psychiatry; 2005 Apr; 57(8):885-94. PubMed ID: 15820709
[TBL] [Abstract][Full Text] [Related]
40. Short-period effects of zirconia and titanium on osteoblast microRNAs.
Palmieri A; Pezzetti F; Brunelli G; Lo Muzio L; Scarano A; Scapoli L; Martinelli M; Arlotti M; Guerzoni L; Rubini C; Carinci F
Clin Implant Dent Relat Res; 2008 Sep; 10(3):200-5. PubMed ID: 18241218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
